| P2093 | author name string | Ling Tian | |
| | Jin-zhong Chen | |
| | Jing-lun Xue | |
| | Yu-xiang Fang | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | Clinical outcome prediction by microRNAs in human cancer: a systematic review | Q24289183 |
| | MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN | Q24597730 |
| | Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways | Q24624119 |
| | A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? | Q24629627 |
| | MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 |
| | miR-19 is a key oncogenic component of mir-17-92 | Q24652326 |
| | Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 |
| | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 |
| | Molecular pathology of prostate cancer | Q24672410 |
| | Cancer statistics, 2012 | Q27860574 |
| | The phosphoinositide 3-kinase pathway | Q27860738 |
| | Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 |
| | MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 |
| | MicroRNA expression profiles classify human cancers | Q28032481 |
| | MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice | Q28115423 |
| | Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a | Q28115981 |
| | Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium | Q28116272 |
| | The biology and clinical relevance of the PTEN tumor suppressor pathway | Q28272157 |
| | mir-17-92, a cluster of miRNAs in the midst of the cancer network | Q28275929 |
| | The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism | Q29547302 |
| | MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 |
| | The functions and regulation of the PTEN tumour suppressor | Q29615536 |
| | Targeting PI3K signalling in cancer: opportunities, challenges and limitations | Q29617685 |
| | Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth | Q33733879 |
| | Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits | Q33832537 |
| | STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer | Q34088885 |
| | Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation | Q34109986 |
| | Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. | Q34416068 |
| | microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin | Q34695995 |
| | Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth | Q35168294 |
| | Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers | Q35808718 |
| | Molecular biology of prostate-cancer pathogenesis | Q36470685 |
| | microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN | Q36642781 |
| | Tenets of PTEN tumor suppression | Q37154214 |
| | MicroRNA-based therapeutics for cancer | Q37432033 |
| | PI(3)king apart PTEN's role in cancer. | Q37771785 |
| | The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. | Q37923731 |
| | Prostate cancer overview | Q37948306 |
| | Posttranscriptional regulation of PTEN dosage by noncoding RNAs | Q39287302 |
| | Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells. | Q39387335 |
| | Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis | Q39438566 |
| | miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer | Q39480964 |
| | MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway | Q39560767 |
| | miR‐125b promotes growth of prostate cancer xenograft tumor through targeting pro‐apoptotic genes | Q39649207 |
| | MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). | Q39728869 |
| | Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumors | Q39735950 |
| | Development of chimeric gene regulators for cancer-specific gene therapy with both transcriptional and translational targeting | Q39747000 |
| | MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. | Q39828166 |
| | MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. | Q39843898 |
| | MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN. | Q40434551 |
| | A new human prostate carcinoma cell line, 22Rv1. | Q40933318 |
| | Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line. | Q41295367 |
| | Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. | Q41404265 |
| | Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines. | Q42816598 |
| | Frequent inactivation of PTEN in prostate cancer cell lines and xenografts | Q47855108 |
| | Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. | Q53659259 |
| | MicroRNAs and prostate cancer | Q57140772 |
| | Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone | Q61510111 |
| | The LNCaP cell line--a new model for studies on human prostatic carcinoma | Q71222674 |
| | MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein | Q82270543 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | e75885 | |
| P577 | publication date | 2013-09-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro | |
| P478 | volume | 8 | |